Newsroom | 43885 results
Sorted by: Latest
-
ARCHER Systems Launches AIM to Raise the Standard for Review of Complex Case Records
HOUSTON--(BUSINESS WIRE)--ARCHER Systems, LLC, today announced the launch of AIM, a managed review service designed to help law firms move from complex medical records and supporting documents to organized, submission-ready case materials with greater speed, traceability, and confidence. Built for high-scrutiny pre-settlement and post-settlement case work up and claims administration, AIM combines purpose-built AI with experienced nurse reviewer validation to identify key evidence, verify findi...
-
LifeStream Behavioral Center and Greenspace Health Partner to Advance Data-Informed Behavioral Healthcare Across Central Florida
TORONTO & LEESBURG, Fla.--(BUSINESS WIRE)--Greenspace Health and LifeStream Behavioral Center, a leading nonprofit provider of behavioral health and social services in Central Florida, have partnered to implement Measurement-Based Care (MBC) across LifeStream’s full continuum of programs. The collaboration will leverage data-driven insights and patient-reported outcome measures (PROMs) within the care process to improve service quality and clinical outcomes for thousands of individuals served a...
-
Sutter Health Expands Use of Wearable Ultrasound Tech Across Additional Bay Area Hospitals to Advance Sepsis Care
LOS ANGELES--(BUSINESS WIRE)--Sutter Health is expanding the use of FloPatch, the first wireless, wearable Doppler ultrasound device, across three additional Northern California hospitals: Sutter Solano Medical Center in Vallejo, Sutter’s Mills-Peninsula Medical Center in Burlingame and the Berkeley campus of Sutter’s Alta Bates Summit Medical Center, as part of its ongoing effort to enhance personalized intravenous (IV) fluid management for patients with sepsis and other life-threatening condi...
-
Routine FDA Inspection Completed Successfully With No Findings for Clinilabs
EATONTOWN, N.J.--(BUSINESS WIRE)--Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in CNS drug and device development, today announced it has successfully completed an inspection by the U.S. Food and Drug Administration (FDA) with no observations. This outcome underscores Clinilabs continued commitment to the highest standards of regulatory compliance, operational excellence, and patient safety across its clinical research programs. “Each FDA...
-
TruMetric Launches as a National Calibration Platform
GREENSBORO, Ga.--(BUSINESS WIRE)--Micro Quality Calibration (MQC) and Technical Maintenance Inc. (TMI), two established full-service calibration organizations, announced the formation of TruMetric, a new family of companies combining their industry-leading capabilities to deliver accredited calibration services nationwide. The partnership brings together MQC’s accredited laboratory and on-site calibration expertise with TMI’s strong field presence and embedded lab models. Built on more than 75...
-
RGP Appoints Dr. Roshni Ghosh as Public Sector Industry Leader to Expand Global Growth
DALLAS--(BUSINESS WIRE)--RGP announced the promotion of Dr. Roshni Ghosh to Public Sector Industry Leader....
-
Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements
RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), announced significant progress in the continued expansion of its global clinical manufacturing network. With the ongoing scale-up of its Vetter Development Service offering, the company is taking important steps to provide necessary capacity, advanced technologies, and specialized expertise in response to rising demand for in-human trial material. By further strengthening i...
-
Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces New Manuscript Demonstrating Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies...
-
DEBIOPHARM DÉVOILERA SES DERNIÈRES AVANCÉES EN RECHERCHE PRÉCLINIQUE ET CLINIQUE SUR L’INHIBITION DE LA DDR, LES ADCs À DOUBLE CHARGE UTILE ET LES BIOMARQUEURS BASÉS SUR L’IA LORS DE L’AACR 2026
Lausanne, Suisse--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), société biopharmaceutique indépendante basée en Suisse dont la vocation est de mettre au point les traitements de référence de demain afin de guérir le cancer et les maladies infectieuses, présentera de nouvelles données révolutionnaires lors du congrès annuel 2026 de l’American Association for Cancer Research (AACR) à San Diego, en Californie. L’un des temps forts de la participation au congrès de cette année sera la première...
-
Debiopharm to Unveil New Pre-Clinical and Clinical Research Advances in DDR Inhibition, Dual Payload ADCs, and AI-Driven Biomarkers at AACR 2026
LAUSANNE, Switzerland--(BUSINESS WIRE)--Debiopharm presents new DDR, dual‑payload ADC and AI biomarker research at AACR 2026, including first clinical data from the MYTHIC study....